CBCD Urges the Public to Get Tested for Latent Viruses during National Immunization Awareness Month
Industry: Health & Fitness
State health departments urge the public to speak to their doctors about vaccinations for viral diseases. (1) The CBCD also suggests learning more about latent viruses.
New York (PRUnderground) August 5th, 2014
The CDC says that “Immunizations are one of the top 10 public health accomplishments of the 20th century.” (1) Dr. LaMar Hasbrouck said that “Vaccines are an important step in protecting against serious and sometimes deadly diseases.” (1) Dr. Hasbrouck is the director of the Illinois Department of Public Health. The Center for the Biology of Chronic Disease (CBCD) points out however, that sometimes, when someone is already infected with a latent virus, a vaccine will do nothing to protect that individual. For example, the standard HPV vaccine protects against four HPV strains: 16, 18, 6, and 11. However, if someone is already infected with these strains, the vaccine will not protect against the development of genital warts or cancer. In addition, vaccines are limited in their coverage. For example, the standard vaccine against HPV does not protect against most of the 100 known strains of HPV. For instance, the standard vaccine does not protect against HPV 31, 35, 45, 56, 58, 66, and 68, that also cause genital warts, and sometimes cancer. (2)
Click to learn more about latent viruses.
The CBCD therefore urges everyone infected with a latent virus, such as the human papillomavirus (HPV), the Epstein Barr Virus (EBV), the herpes simplex virus (HSV-1 and HSV-2), the cytomegalovirus (CMV), the varicella zoster virus (VZV), and more to learn about Novirin and Gene-Eden-VIR. The formula of Novirin and Gene-Eden-VIR was tested by Hanan Polansky and Edan Itzkovitz from the Center for the Biology of Chronic Disease (CBCD) in two clinical studies that followed FDA guidelines. The studies showed that the Novirin and Gene-Eden-VIR formula is effective against the HPV, HSV-1, HSV-2, EBV and other viruses. The clinical studies were published in the peer reviewed, medical journal Pharmacology & Pharmacy, the first, in a special edition on Advances in Antiviral Drugs. Study authors wrote that, “individuals infected with the (HPV, HSV-1, HSV-2, EBV, and other viruses)…reported a safe decrease in their symptoms following treatment with Gene-Eden-VIR.” (3) The study authors also wrote that, “We observed a statistically significant decrease in the severity, duration, and frequency of symptoms.” (3)
Gene-Eden-VIR and Novirin are natural antiviral dietary supplements. Their formula contains five natural ingredients: Selenium, Camellia Sinesis Extract, Quercetin, Cinnamomum Extract, and Licorice Extract. The first ingredient is a trace element, and the other four are plant extracts. Each ingredient and its dose was chosen through a scientific approach. Scientists at polyDNA, the company that invented and patented the formula, scanned thousands of scientific and medical papers published in various medical and scientific journals, and identified the safest and most effective natural ingredients against latent viruses. To date, Novirin and Gene-Eden-VIR are the only natural antiviral products on the market with published clinical studies that support their claims.
Most scientists and physicians believe that latent viruses cause no diseases or symptoms. The FDA even states on its website: “Some viruses, however, can enter a state known as latency in which the virus is not being replicated. In the latent state the virus does not cause disease.” (4) As a result, current standard medical practices don’t target latent viruses.
In contrast to this belief, the Microcompetition with Foreign DNA theory, proposed by Hanan Polansky in 2003, describes how viruses, during their latent phase, can cause a chronic disease. (5)
Click to learn more about Microcompetition, by reading Dr. Polansky’s book.
During National Immunization Awareness Month, the CBCD believes it is important to remember that most vaccines designed to target active viruses help save lives. To target latent viruses however, the CBCD recommends Novirin or Gene-Eden-VIR.
(1) TheTelegraph.com – National Immunization Awareness Month. Last updated August 03, 2014.
(2) MedTV – High-Risk HPV
(3) Polansky H, Itzkovitz E. Gene-Eden-VIR Is Antiviral: Results of a Post Marketing Clinical Study. Pharmacology & Pharmacy, 2013, 4, 1-8
(4) FDA – Long-Term Follow-Up Of Gene Transfer Patients. Published October 24, 2001.
(5) The Center for the Biology of Chronic Disease – Microcompetition with Foreign DNA and the Origin of Chronic Disease. Published in 2003.
The Center for the Biology of Chronic Disease (http://www.cbcd.net) is a not-for-profit tax-exempt organization under section 501(c) 3 of the IRS tax code. The center’s mission is to advance the research on the biology of chronic disease and to accelerate the discovery of a cure for these diseases. The CBCD first published Dr. Hanan Polansky’s highly acclaimed “Purple” book, entitled “Microcompetition with Foreign DNA and the Origin of Chronic Disease” in 2003. In this book, he explains how foreign DNA fragments can cause many major diseases. The book has been read by more than 5,000 scientists around the world, and has been reviewed in more than 20 leading scientific journals. These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure, or prevent any disease.